Literature DB >> 31098708

Predictors of imminent non-vertebral fracture in elderly women with osteoporosis, low bone mass, or a history of fracture, based on data from the population-based Canadian Multicentre Osteoporosis Study (CaMos).

Jonathan D Adachi1, Claudie Berger2, Rich Barron3, Derek Weycker4, Tassos P Anastassiades5, K Shawn Davison6, David A Hanley7, George Ioannidis1, Stuart A Jackson8, Robert G Josse9, Stephanie M Kaiser10, Christopher S Kovacs11, William D Leslie12, Suzanne N Morin13, Alexandra Papaioannou1, Jerilynn C Prior14, Erinda Shyta15, Amanda Silvia15, Tanveer Towheed5, David Goltzman13.   

Abstract

Using data from the Canadian Multicentre Osteoporosis Study, several risk factors predictive of imminent (2-year) risk of low-trauma non-vertebral fracture among high-risk women were identified, including history of falls, history of low-trauma fracture, poorer physical function, and lower T score. Careful consideration should be given to targeting this population for therapy.
PURPOSE: Fracture risk assessment has focused on a long-term horizon and populations with a broad risk range. For elderly women with osteoporosis or low bone mass, or a history of fragility fractures ("high-risk women"), risk prediction over a shorter horizon may have greater clinical relevance.
METHODS: A repeated-observations design and data from the Canadian Multicentre Osteoporosis Study were employed. Study population comprised women aged ≥ 65 years with T score (total hip, femoral neck, spine) ≤ - 1.0 or prior fracture. Hazard ratios (HR) for predictors of low-trauma non-vertebral fracture during 2-year follow-up were estimated using multivariable shared frailty model.
RESULTS: The study population included 3228 women who contributed 5004 observations; 4.8% experienced low-trauma non-vertebral fracture during the 2-year follow-up. In bivariate analyses, important risk factors included age, back pain, history of falls, history of low-trauma fracture, physical function, health status, and total hip T score. In multivariable analyses, only four independent predictors were identified: falls in past 12 months (≥ 2 falls: HR = 1.9; 1 fall: HR = 1.5), low-trauma fracture in past 12 months (≥ 1 fracture: HR = 1.7), SF-36 physical component summary score (≤ 42.0: HR = 1.6), and total hip T score (≤ - 3.5: HR = 3.7; > - 3.5 to ≤ - 2.5: HR = 2.5; > - 2.5 to ≤ - 1: HR = 1.3).
CONCLUSIONS: Imminent risk of low-trauma non-vertebral fracture is elevated among high-risk women with a history of falls or low-trauma fracture, poorer physical function, and lower T score. Careful consideration should be given to identifying and targeting this population for therapy.

Entities:  

Keywords:  Bone; Fractures; Osteoporosis; Risk factors

Mesh:

Year:  2019        PMID: 31098708     DOI: 10.1007/s11657-019-0598-x

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  8 in total

1.  Risk of falls in patients with low bone mineral density : Analysis of placebo arms from clinical trials.

Authors:  Luis Möckel
Journal:  Z Gerontol Geriatr       Date:  2020-09-23       Impact factor: 1.281

2.  Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM).

Authors:  Sören Möller; Michael K Skjødt; Lin Yan; Bo Abrahamsen; Lisa M Lix; Eugene V McCloskey; Helena Johansson; Nicholas C Harvey; John A Kanis; Katrine Hass Rubin; William D Leslie
Journal:  Osteoporos Int       Date:  2021-10-01       Impact factor: 4.507

3.  Fragility fracture identifies patients at imminent risk for subsequent fracture: real-world retrospective database study in Ontario, Canada.

Authors:  Jonathan D Adachi; Jacques P Brown; Emil Schemitsch; Jean-Eric Tarride; Vivien Brown; Alan D Bell; Maureen Reiner; Millicent Packalen; Ponda Motsepe-Ditshego; Natasha Burke; Lubomira Slatkovska
Journal:  BMC Musculoskelet Disord       Date:  2021-02-26       Impact factor: 2.362

4.  Hip fracture predicts subsequent hip fracture: a retrospective observational study to support a call to early hip fracture prevention efforts in post-fracture patients.

Authors:  Emil Schemitsch; Jonathan D Adachi; Jacques P Brown; Jean-Eric Tarride; Natasha Burke; Thiago Oliveira; Lubomira Slatkovska
Journal:  Osteoporos Int       Date:  2021-08-11       Impact factor: 4.507

5.  Cost-effectiveness analysis of five drugs for treating postmenopausal women in the United States with osteoporosis and a very high fracture risk.

Authors:  C Luo; S-X Qin; Q-Y Wang; Y-F Li; X-L Qu; C Yue; L Hu; Z-F Sheng; X-B Wang; X-M Wan
Journal:  J Endocrinol Invest       Date:  2022-08-31       Impact factor: 5.467

6.  Jintiange combined with alfacalcidol improves muscle strength and balance in primary osteoporosis: A randomized, double-blind, double-dummy, positive-controlled, multicenter clinical trial.

Authors:  Hanting Liang; Ou Wang; Zhifeng Cheng; Peijin Xia; Liang Wang; Jie Shen; Xijian Kong; Yuhong Zeng; Aijun Chao; Limei Yan; Hua Lin; Haibiao Sun; Qun Cheng; Mei Zhu; Zhenming Hu; Zhenlin Zhang; Hai Tang; Weibo Xia
Journal:  J Orthop Translat       Date:  2022-08-24       Impact factor: 4.889

7.  Risk factors for a second nonsimultaneous hip fracture in a prospective cohort study.

Authors:  Ricardo Larrainzar-Garijo; Adolfo Díez-Pérez; Esther Fernández-Tormos; Daniel Prieto-Alhambra
Journal:  Arch Orthop Trauma Surg       Date:  2021-06-14       Impact factor: 2.928

8.  Risk of falls in postmenopausal women treated with romosozumab: Preliminary indices from a meta-analysis of randomized, controlled trials.

Authors:  Luis Möckel; Matthias Bartneck; Christina Möckel
Journal:  Osteoporos Sarcopenia       Date:  2020-02-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.